000285491 001__ 285491
000285491 005__ 20260311151203.0
000285491 0247_ $$2doi$$a10.1016/j.neuroimage.2026.121821
000285491 0247_ $$2pmid$$apmid:41722883
000285491 0247_ $$2ISSN$$a1053-8119
000285491 0247_ $$2ISSN$$a1095-9572
000285491 037__ $$aDZNE-2026-00267
000285491 041__ $$aEnglish
000285491 082__ $$a610
000285491 1001_ $$aFuxjäger, Isabelle S$$b0
000285491 245__ $$aLongitudinal comparison of adaptive neuroplasticity in two rat models of unilateral vestibulopathy by dual-tracer [18F]FDG and [18F]UCB-H PET.
000285491 260__ $$aOrlando, Fla.$$bAcademic Press$$c2026
000285491 3367_ $$2DRIVER$$aarticle
000285491 3367_ $$2DataCite$$aOutput Types/Journal article
000285491 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1773238231_15722
000285491 3367_ $$2BibTeX$$aARTICLE
000285491 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000285491 3367_ $$00$$2EndNote$$aJournal Article
000285491 520__ $$aAnimal models of acute unilateral vestibulopathy are well established for the study of adaptive lesion-induced neuroplasticity, because symptoms of acute vestibular asymmetry such as nystagmus and postural imbalance recover over time as central vestibular compensation mechanisms commence action. The purpose of this study was to compare these mechanisms in a postganglionic complete unilateral vestibular neurectomy model (UVN) vs. a preganglionic incomplete chemical unilateral labyrinthectomy model (cUL) using a longitudinal [18F]FDG/[18F]UCB-H dual tracer positron emission tomography (PET) approach accompanied by multimodal behavioral testing. Twenty-four male Sprague Dawley rats underwent either cUL or UVN. Postoperatively, [18F]FDG PETs were conducted weekly for four weeks to depict changes of [18F]FDG as a surrogate for functional plasticity, and [18F]UCB-H PETs were carried out at three time points over nine weeks to visualize alterations in synaptic density indicating structural plasticity. Behavioral recovery was assessed weekly using a clinical scoring system and open field evaluation. Behavioral data reflected comparable compensation dynamics between groups. Both [18F]FDG and [18F]UCB-H PET revealed a similar spatial pattern of brain regions involved in adaptive neuroplasticity. However, while the relative extent of [18F]FDG uptake in these networks was comparable across both models, synaptic density changes were more pronounced in UVN vs. cUL. Specifically, synaptic density in the vestibular nuclei was significantly lower after UVN, accompanied by a more intense compensatory increase in sensorimotor cortical areas. In conclusion, synaptic density imaging may be a more sensitive method to depict subtle differences in mechanisms of lesion-induced adaptive neuroplasticity than traditional techniques such as imaging of glucose metabolism.
000285491 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000285491 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000285491 650_7 $$2Other$$aAcute unilateral vestibulopathy
000285491 650_7 $$2Other$$aAnimal models
000285491 650_7 $$2Other$$aDizziness
000285491 650_7 $$2Other$$aNeuroimaging
000285491 650_7 $$2Other$$aSynaptic density
000285491 650_7 $$2Other$$aUnilateral chemical labyrinthectomy
000285491 650_7 $$2Other$$aUnilateral vestibular neurectomy
000285491 650_7 $$2Other$$aVertigo
000285491 7001_ $$aAntons, Melissa$$b1
000285491 7001_ $$aMarouane, Emna$$b2
000285491 7001_ $$aLeschiutta, Giulia$$b3
000285491 7001_ $$aOos, Rosel$$b4
000285491 7001_ $$aPalumbo, Giovanna$$b5
000285491 7001_ $$aSteenken, Dilara$$b6
000285491 7001_ $$aLindner, Simon$$b7
000285491 7001_ $$aZiegler, Sibylle$$b8
000285491 7001_ $$aBartenstein, Peter$$b9
000285491 7001_ $$0P:(DE-2719)9001539$$aBrendel, Matthias$$b10$$udzne
000285491 7001_ $$aWerner, Rudolf$$b11
000285491 7001_ $$aZwergal, Andreas$$b12
000285491 773__ $$0PERI:(DE-600)1471418-8$$a10.1016/j.neuroimage.2026.121821$$gVol. 329, p. 121821 -$$p121821$$tNeuroImage$$v329$$x1053-8119$$y2026
000285491 8564_ $$uhttps://pub.dzne.de/record/285491/files/DZNE-2026-00267.pdf$$yRestricted
000285491 8564_ $$uhttps://pub.dzne.de/record/285491/files/DZNE-2026-00267.pdf?subformat=pdfa$$xpdfa$$yRestricted
000285491 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001539$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b10$$kDZNE
000285491 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000285491 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2025-11-11$$wger
000285491 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROIMAGE : 2022$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2025-08-21T14:46:23Z
000285491 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2025-08-21T14:46:23Z
000285491 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2025-08-21T14:46:23Z
000285491 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEUROIMAGE : 2022$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2025-11-11
000285491 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2025-11-11
000285491 9201_ $$0I:(DE-2719)1110007$$kAG Haass$$lMolecular Neurodegeneration$$x0
000285491 980__ $$ajournal
000285491 980__ $$aEDITORS
000285491 980__ $$aVDBINPRINT
000285491 980__ $$aI:(DE-2719)1110007
000285491 980__ $$aUNRESTRICTED